| Message: | (Arimidex) CAS: 120511-73-1
CAS: 120511-73-1
Assay: 99%.
Packing: 1Kg/foil bag.
Delivery: Courier.
MF: C17H19N5
MW: 293.37
Character: White crystalline powder.
Melting Point: 81-82
Appearance: Off-white crystalline powder
Packing: Aluminum foil bag+cardboard box, 100 grams/bag; 500 grams/bag; 1kg/bag
Used: Raw material powder
Min. Order quantity: 5g
Terms of payment: T/T, Western Union, Money Gram
Way of shipping: EMS, DHL, FedEx, UPS
Product details:
An aromatase-inhibiting drug approved for treatment of breast cancer after surgery, as well as for metastasis in both pre and postmenopausal women. The severity of breast cancer is increased by estrogen, as sexhormones cause hyperplasia, and differentiation at estrogen receptor sites. Works by inhibiting the synthesis of estrogen.
The trial suggested that is the preferred medical therapy for Postmenopausal women with localized breast cancer that is estrogen receptor (ER) positive.
Three azole potent selective aromatase inhibitors, which inhibit rely on aromatase cytochrome P -450 to block estrogen biosynthesis, and the main factors of estrogen to stimulate breast cancer cell growth. It can treat breast cancer, especially suitable for those who relapse after treatment with hormone auxiliary advanced breast cancer after menopause women. |
my account
